Board adopts multiple ordinances and resolutions, including opioid settlements and housing grants; calendar notes

The San Francisco Board of Supervisors on Sept. 12 adopted a number of ordinances and resolutions on the adoption-without-committee calendar. Most were approved under the standard “same house, same call” procedure with no extended debate. Key items adopted or advanced include opioid litigation settlements, a financing authorization, lease approvals, and several grant amendments related to homelessness services.

Highlights

- Opioid litigation settlements (Items 2–4): The board approved ordinances authorizing settlements in lawsuits related to opioid dispensing and marketing. - Item 2: Settlement with Walgreens Co. for approximately $229,000,000 related to allegations of improper dispensing of prescription opioids at its pharmacies. The ordinance was passed. - Item 3: Settlement with Cephalon Inc., Actavis/Teva-affiliated entities and related companies for approximately $24,800,000 concerning allegedly false or misleading opioid marketing. The ordinance was passed. - Item 4: Settlement with Allergan Finance LLC for approximately $12,900,000 for allegedly false or misleading marketing of opioids. The ordinance was passed.

- Financing and leases - Item 6: Ordinance authorizing certificates of participation in an aggregate principal amount of $77,000,000 to finance and refinance certain city capital projects — passed on first reading. - Item 7: Resolution approving a lease of city…